A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT

April 4, 2018 updated by: Mirjam Lukasse, Oslo Metropolitan University

A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With Gestational Diabetes Mellitus - RCT

In this study, the investigators will test a new way to communicate advice on diet and lifestyle to women with gestational diabetes mellitus by app downloaded on women's smartphone. The app wishes to motivate women to have a healthy diet, and be physically active. It allows automatic transfer of blood glucose measures from the glucose meter to the smartphone. The women will answer questionnaires during pregnancy and be followed up three months postpartum.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Gestational diabetes mellitus (GDM), diabetes occuring for the first time during pregnancy, is an increasing problem worldwide. It may affect both the woman's and their offspring's health. Women with GDM have an increased risk of developing type 2 diabetes later in life. Pregnancy, offers a window of opportunity to instigate lasting changes beneficial for them and their families. Considering new technology available and used by women generally, new methods to communicate lifestyle and dietary advice are required.

The present study, a multi-center, randomised controlled trial includes five outpatients clinics in the greater Oslo Region and will include 230 pregnant women with gestational diabets mellitus. Data will be collected by three questionnaires during the study period, one at entry, before 33+0 weeks of gestation, one at 36 weeks and the last questionnaire at around three months postpartum. During pregnancy, the questionniares will be answered using an iPad while the last questionnaire will be on a website or through an interview.

Additional information will be collected from the women's medical record.

The intervention in this study is an app, called the Pregnant+ app (Gravid+) for smartphone. The app aims to reach women who are fluent in either Norwegian, Urdu or Somali. It has been translated from Norwegian and culturally adapted to women speaking Urdu or Somali. Women participating in the study can choose between different food cultures and they can set their personal lifestyle goals. Information about gestational diabetes, psysical activity, diet and food recipes are provided in the app. Half of the women in this study, will be given the app, downloaded on their smartphone.The opportunity to automatically transfer bloodglucose measures to the smartphone, presented in either a list or a graph, gives women an overview and therefore easier controll over their glucose levels.

The intervention will take place in the ordinary consultation at the outpatient clinics and no extra consultation are needed.

The data will be analysed according to intention to treat methods and with a parcicipatin rate on 75% it will take approximately 20 months to recruite 230 pregnant women. To detect a differences of 10% between the intervention group and the control group, 115 women are required in each group.

The Regional Committees for Medical and Health Research Ethics South East, (REK) reviewed the investigators' application and deemed ethical approval not required as the investigators' study does not test new medication or treatment, nor seeks to find new information about GDM but only tests a new way of communicating known and approved lifestyle advice to women with GDM.

For each hospital the investigators received approval from the appropriate Board for patient privacy protection (PVO: Personvernombud). The study was approved at each hospital by the responsible medical officer.

The investigators' study has been approved by the Norwegian Social Science Data Services.

The RCT will be published in an international peer-reviewed scientific journal.

Study Type

Interventional

Enrollment (Actual)

238

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 4950
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • First visit with gestational diabetes in this pregnancy
  • Has her own smartphone
  • Pregnancy up to 32 weeks and 6 days of gestation
  • Fluent in Norwegian, Urdu or Somali
  • Aged 18 years old and older

Exclusion Criteria:

  • Pregnant with more than one fetus
  • Lactose or gluten intolerance
  • Known type 1 diabetes (insulin dependent)
  • Known type 2 diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pregnant+ app for smartphone (Gravid+)
The intervention consists of the Pregnant+app downloaded on women's smartphone. The app contains culturally adapted information about physical activity, diet and management of GDM. The Gravid+app will be available in Norwegain, Urdu and Somali. Women will have the opportunity to automatically transfer their blood glucose levels to their smartphones via Bluetooth.
The Pregnant+app for smartphone with information about a healthy diet, physical activity and management of gestational diabetes mellitus.
No Intervention: No admission to Pregnant+ app (Gravid+)
The control group will receive standard care at the outpatient departments. Participants to not receive the Pregnancy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral glucose tolerance test (OGTT), fasting and 2 hours blood glucose level after intake up til 75gr glucose (1.75gr/kg body weight)
Time Frame: Approximately three months after delivery.
Part of routine care for women who had GDM, is an OGTT about three months postpartum, taken at their laboratory and reported to the investigators.Number of participants with level below 7.5 mmol
Approximately three months after delivery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complications of pregnancy
Time Frame: Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Raised BP, vaginal bleeding, amniotic fluid leakage, preeclampsia, nausea and vomitting, Braxton Hicks Contractions, UTI, Candida vaginal infection, pelvic girdle pain
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Dietary intake measured by "Fit for fødsel Food questionnaire"
Time Frame: Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Fit for fødsel Food questionnaire, 41 questions. Number of participants following ten items of advice on low glucose, high fiber diet.
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Knowledge of gestational diabetes
Time Frame: Data will be collected prior to 33 weeks gestation, and at 36 weeks gestation
7 questions assessing knowledge of gestational diabetes and understanding of glucose measurements and control of those. Number of participants with high understanding of GDM at 36 weeks, and number of participants with increasing knowledge.
Data will be collected prior to 33 weeks gestation, and at 36 weeks gestation
Physical activity
Time Frame: Data wil be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum

PPAQ:Pregnancy Physical Activity Questionnaire (37 questions). Comparison of participants in both arms of the study for Level of physical activity.

Number of participants with low, moderate or high level of activity.

Data wil be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Depression
Time Frame: Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Edinburgh Depression Scale- short version, 5 questions. Number of participants with depression. Cut-off at either total score of 7 or 8.
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Motivation for physical activity
Time Frame: Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
4 questions assessing women's motivation to be physically active, number of women with high score and increasing score.
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Motivation for eating healthy
Time Frame: Data will be collected prior to 33 weeks gestation, at 36 weeks, up to 4 months postpartum
3 questions assessing women's motivation to eat healthy, number of women with high score and increasing score.
Data will be collected prior to 33 weeks gestation, at 36 weeks, up to 4 months postpartum
Mode of delivery and complications at birth for the mother
Time Frame: at birth
From the Medical records, number of women for each group: induction, mode of delivery, shoulderdystocia, postpartum haemorrhage, Sphincter rupture, episiotomi, manual removal of placenta, Hb below 11 gr/dl, infection, removal of retained products.
at birth
Complications for the newborn
Time Frame: at birth
Number of newborns who were transferred to intensive care unit, who were diagnosed with hypoglycaemia, information from the Medical records.
at birth
Condition of the newborn
Time Frame: at birth and approx three months postpartum
Number of newborns with Apgar score below 7 at 5 minutes, birth weight above different cut-offs (3.5 kg and 4kg), full breastfeeding and other nutrition from pasient notes and 3 months postpartum questionnaire.
at birth and approx three months postpartum
Starting medication for controlling blood glucose levels for the pregnant woman
Time Frame: during pregnancy
Number of patients who start to use insulin or Metformin during pregnancy, information from the patient notes
during pregnancy
Blood glucose control during pregnancy
Time Frame: during pregnancy
Number of patients with, fasting glucose over 5.5 gr/dl, HbA1c above 7.0% at 30,32,34,36,38 and 40 weeks
during pregnancy
HbA1c
Time Frame: Approx three months postpartum
Measured at home by visiting researcher, finger prick blood.
Approx three months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

August 31, 2015

First Submitted That Met QC Criteria

October 27, 2015

First Posted (Estimate)

October 28, 2015

Study Record Updates

Last Update Posted (Actual)

April 5, 2018

Last Update Submitted That Met QC Criteria

April 4, 2018

Last Verified

April 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Diabetes Mellitus

Clinical Trials on Pregnant+ app for smartphone

Subscribe